NTC at CPhI - Frankfurt 2019 - Stand 91B71

  • Nov 05, 2019

CPhI Worldwide, 5-7 November 2019.
See you in Frankfurt.

Lertal® significantly favors good functioning of the immune system

  • Sept 03, 2019

Lertal® significantly favors good functioning of the immune system the immune system’s activity and improves the management of rhinoconjunctivitis in children.

NTC ACQUIRES FROM NMTECH UK TiAb AND SIAB BASED TECHNOLOGY

  • June 12, 2019

Milan, Italy, June 12, 2019 – NTC focuses on strengthening its gynecology, dermatology and ophthalmology portfolio and pipeline.

NEW LIFE FOR PATIENTS SUFFERING FROM BLEPHARITIS: a controlled clinical study was presented on Blefastop, an ocular and periocular innovative therapeutic solution as adjuvant in blepharitis.

  • June 5, 2019

Milan, June 5, 2019 – Recently, a controlled clinical study was presented on Blefastop, an ocular and periocular innovative therapeutic solution as adjuvant in blepharitis.